Cabka (CABKA) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
1 Feb, 2026Executive summary
Revenue for H1 2024 declined by 11% year-over-year to €92.3 million, mainly due to intentional price reductions and weakness in U.S. Customized Solutions and Contract Manufacturing.
Gross margin improved by 4 percentage points to 50.5%, attributed to operational effectiveness, automation, and higher value-add products.
EBITDA margin dropped to 11.3% from 12.9% last year, with EBITDA at €10.4 million, impacted by lower sales and inflationary cost pressures.
Net income for H1 2024 was a loss of €1.9 million, compared to a profit in H1 2023.
New CEO appointed, focusing on innovation, sustainable growth, and strategic realignment, with a Capital Markets Day scheduled for November 25.
Financial highlights
Revenue fell from €104.3 million to €92.3 million year-over-year, with a 5% top-line impact from price adjustments.
Volume grew by 15% in performing segments, indicating market share gains despite overall revenue decline.
Net debt increased to €74 million including operational leases; net debt at €56.8 million as of HY2024 excluding leases.
Capital investments reduced to €9.3 million, focused on automation, maintenance, and U.S. restoration.
Net working capital at 20% of sales, reflecting inventory buildup and longer payment terms for new customers.
Outlook and guidance
Full-year 2024 revenue guidance revised to €180–185 million, down from prior expectations.
EBITDA margin expected to recover to 13–15% (€23–27 million) by year-end.
U.S. Customized Solutions and Contract Manufacturing expected to remain under pressure; other segments to continue growth.
Medium-term guidance targets high single-digit revenue growth and EBITDA margin toward 17% by 2026.
Dividend of €0.15 per share to be paid on August 16, 2024.
Latest events from Cabka
- EBITDA margin rose to 11.7% as net loss narrowed and net debt fell, despite a 1% revenue dip.CABKA
H2 20255 Mar 2026 - 2024 sales fell 8% but margin rose to 50.9%; portfolio growth and cost control prioritized.CABKA
H2 202426 Dec 2025 - Gross margin rose to 51.7% as US sales grew and cost controls offset lower European demand.CABKA
H1 202523 Nov 2025 - Staged plan targets €215M+ revenue by 2028 and €300M+ with margin expansion by 2030.CABKA
CMD 202519 Nov 2025 - Stable Q3 sales and improved EBITDA margin, with 2025 outlook matching prior year.CABKA
Q3 2025 TU21 Oct 2025 - Q1 2025 sales held steady at €44.1 million, with stable outlook despite market volatility.CABKA
Q1 2025 TU19 Jun 2025 - Targets €300m revenue and 15–17% EBITDA margin by 2030, led by innovation and sustainability.CABKA
CMD 202413 Jun 2025 - Q3 sales up 8% year-over-year, with full-year guidance reaffirmed amid segment growth.CABKA
Q3 2024 TU13 Jun 2025